
Ingredion Incorporated (NYSE:INGR) reported second-quarter net sales of $1.85 billion, up 1%, while adjusted operating income fell 5% to $258 million.
Reported operating income declined 31% to $188 million, while adjusted diluted EPS slipped to $2.82 from $2.87 one year earlier.
U.S./CAN operating income fell 33% to $58 million after Argo production issues, while Texture & Healthful Solutions income rose 5% to $117 million.
Following the announcement, Ingredion's share price was up 0.1% at $100.50, as the company reaffirmed adjusted EPS guidance of $10.30–$10.90.
Ingredion sold a 51% stake in its Pakistan business for $165 million and retained a 20% ownership interest.
Meanwhile, Tate & Lyle shareholders accepted Ingredion’s 595 pence cash offer, with completion expected in the second half of 2027 subject to approvals.
Ingredion (NYSE:INGR) reported record full-year 2025 results on Tuesday, underscoring the resilience of its high-margin specialty ingredients despite operational headwinds in North America.
Ingredion (NYSE:INGR) lowered its full-year earnings forecast after a difficult first quarter where operational setbacks in its core North American business more than offset steady demand for its specialty ingredient portfolio.
Ingredion (NYSE:INGR) announced the acquisition of Benicaros, a proprietary prebiotic fiber line clinically shown to support immune health, marking a strategic expansion of the ingredient provider's plant-based and functional nutrition portfolio.